Home›Trial›NCT07240116
🔬NCT07240116Phase 1ACTIVE NOT RECRUITING

Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects

Study Summary

This single-center, randomized, open-label study will assess the relative bioavailability of 2 miricorilant (CORT118335) tablet formulations.

Conditions
Healthy
Interventions / Drugs
Miricorilant Treatment AMiricorilant Treatment BMiricorilant Treatment CMiricorilant Treatment D
View on ClinicalTrials.gov ↗
Sponsor
CORT
Corcept Therapeutics
Endocrinology
C59/100
Study Details
Enrollment18 participants
Primary Completion—
Lead SponsorCorcept Therapeutics
Data Retrieved2026-04-11 04:10:22.666680+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.